Re: hepatitida C - zjištěné protilátky u spolubydlící v porodnici

- "odkud bereš jistotu"



Nelson Textbook of Pediatrics 19th edition. 2011, updated 2014,
Part XVIII, Section 6, Chapter 350

Blackard JT, Shata MT, Shire NJ, Sherman KE: Acute hepatitis C virus infection: a chronic problem. Hepatology. 47 (1):321-331 2008 18161707

Bortolotti F, Verucchi G, Camma C, et al.: Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroentrology. 134:1900-1907 2008

Fernandez-Rodriguez CM, Alonso S, Martinez SM, et al.: Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response. Am J Gastroenterol. 105:2164-2172 2010 20700116

Hoofnagle JH: A step forward in therapy for hepatitis C. N Engl J Med. 360 (18):1899-1901 2009 19403908

Maheshwari A, Ray S, Thuluvath PJ: Acute hepatitis C. Lancet. 372:321-332 2008 18657711

McHutchison JG, Everson GT, Gordon SC, et al.: Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med. 360:1827-1838 2009 19403902

McHutchison JG, Lawitz EJ, Shiffman ML, et al.: Peginterferon alfa-2b or alfa 2a with ribavirin for treatment of hepatitis C infection. N Engl J Med. 361:580-592 2009 19625712

Milazzo L, Antinori S: STAT-C: a full revolution or just a step forward. Lancet. 376:662-663 2010 20692692

Muir AJ, Shiffman ML, Zaman A, et al.: Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology. 52:822-832 2010 20564352

Nash KL, Bentley I, Hirschfield GM: Managing hepatitis C virus infection. BMJ. 339:37-42 2009

Rodriguez-Torres M, Jeffers LJ, Sheikh MY, et al.: Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. N Engl J Med. 360:257-267 2009 19144941

http://www.who.int/mediacentre/factsheets/fs164/en/

http://www.epidemic.org/thefacts/hepatitisc/transmission/